Effective treatment of a child with adenoidal hypertrophy and severe asthma by omalizumab: a case report
Abstract Background Childhood adenoid hypertrophy (AH) is common and is often associated with allergic asthma, resulting in complications like obstructive sleep apnea syndrome (OSAS). Management of the disease and its complications is often challenging. Case presentation We report here a case of a 1...
Main Authors: | Haijing Sui, Huishan Zhang, Wei Ding, Zuotao Zhao, Jiali Mo, Jiexin Yuan, Leping Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-022-00732-9 |
Similar Items
-
Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
by: Tajiri T, et al.
Published: (2023-01-01) -
Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases
by: J. Bousquet, et al.
Published: (2008-04-01) -
Omalizumab Treatment in Patients with Severe Allergic Asthma
by: Tuğba Songül Tat, et al.
Published: (2017-09-01) -
Impact of Direct and Indirect Cat Allergen Exposure Patterns on Allergic Rhinitis and Asthma in Cat-Sensitized Patients
by: Osman Ozan Yegit
Published: (2023-09-01) -
Prevalence and risk factors for allergic rhinitis and asthma in geriatric outpatients in three big cities of Turkey
by: Asli Kilavuz, et al.
Published: (2020-06-01)